| Promoter Name | Relation | Shares Held Pre-Transaction | % of Total Share Capital Pre-Transaction | Shares Transferred | Shares Held Post-Transaction | % of Total Share Capital Post-Transaction |
|---|---|---|---|---|---|---|
| Mr. Paresh Chawla | Acquirer / Transferee | 3,686,450 | 17.52% | +3,521,760 | 7,208,210 | 34.26% |
| Mr. Mahendra Singh Chawla | Seller / Transferor | 2,906,760 | 13.82% | -2,905,760 | 1,000 | 0.005% |
| Mrs. Asha Chawla | Seller / Transferor | 616,700 | 2.93% | -616,000 | 700 | 0.003% |
Transaction Details
The inter-se transfer involved Mr. Paresh Chawla acquiring shares from two other members of the promoter group:
- From Mr. Mahendra Singh Chawla: Mr. Paresh Chawla acquired 2,905,760 equity shares.
- From Mrs. Asha Chawla: Mr. Paresh Chawla acquired 616,000 equity shares.
The total acquisition by Mr. Paresh Chawla amounts to 3,521,760 equity shares, representing 16.74% of the diluted share capital of Alpa Laboratories Ltd. The transactions were executed on two dates: June 13, 2025, and June 17, 2025. As these shares were transferred by way of gift, there was no monetary consideration involved in the transaction. This type of transfer is common for succession planning or restructuring holdings within a promoter family or group.
The company, in its filing dated June 17, 2025, signed by Srashti Chopra, Company Secretary, confirmed the receipt of these disclosures. A separate disclosure, also dated June 17, 2025, was submitted by Mr. Paresh Chawla, detailing his acquisition. Mr. Chawla resides at 11, Ruby Villa, Agni enclave, Silver springs township phase-1 Mundla Nayata, Indore MP 452020.
Regulatory Compliance and Exemptions
The disclosures were filed in compliance with the SEBI (SAST) Regulations, 2011. Specifically, the company received:
- Disclosure under Regulation 10(6) from Mr. Paresh Chawla for the acquisition of shares via inter-se transfer (by way of gift).
- Disclosure under Regulation 29(1) and 29(2) from Mr. Paresh Chawla for the same acquisition.
- Disclosure under Regulation 29(2) from Mr. Mahendra Singh Chawla for the disposal of shares via inter-se transfer (by way of gift).
The acquisition by Mr. Paresh Chawla falls under the exemption provided in Regulation 10(1)(a)(ii) of the SEBI (SAST) Regulations, 2011. This regulation exempts acquisitions pursuant to inter-se transfers of shares among qualifying persons (which includes promoters and promoter group members) from the obligation to make an open offer, provided certain conditions are met. The disclosure for the proposed acquisition under Regulation 10(5) was filed with the stock exchanges on June 6, 2025.
Impact on Shareholding
Following these transactions, Mr. Paresh Chawla's shareholding in Alpa Laboratories Ltd. has significantly increased. His holding rose from 3,686,450 shares (17.52% of total share capital) to 7,208,210 shares (34.26% of total share capital).
Concurrently, the shareholding of the sellers has decreased. Mr. Mahendra Singh Chawla's holding reduced from 2,906,760 shares (13.82%) to a nominal 1,000 shares (0.005%). Mrs. Asha Chawla's holding decreased from 616,700 shares (2.93%) to 700 shares (0.003%).
Crucially, Alpa Laboratories has emphasized that "there is no change in the total shareholding of Promoter and Promoter Group of the Company pre and post transfer of shares." This indicates that the shares have merely been redistributed among the existing promoter group members, without altering the collective control or ownership percentage of the promoter group in the company.
About Alpa Laboratories Ltd.
Alpa Laboratories Ltd., with CIN L85195MP1988PLC004446, is engaged in the pharmaceutical business. Its registered office is located at 33/2, A.B. Road, Pigdamber-453446, Distt. Indore (M.P.) India. The company's shares are listed on both the National Stock Exchange of India Limited (NSE) under the scrip code ALPA and the Bombay Stock Exchange Limited (BSE) under the scrip code 532878.
The company has requested the stock exchanges to take note of these disclosures for compliance purposes and to update their records accordingly.
